The review summarizes extramammary Paget's disease (EMPD), emphasizing the increased risk of internal malignancies and the need for thorough cancer screening. Analyzing data from 3,723 EMPD patients in the SEER program, researchers found a significant rise in mortality from breast (SMR 2.62) and colorectal cancers (SMR 1.83), with 272 cancer-related deaths overall (SMR 2.08). Notably, bladder, prostate, and gastric cancers did not show increased mortality risk. The findings support current guidelines for age-appropriate colonoscopy and mammography in EMPD patients while questioning the necessity for universal screening for bladder and prostate cancers. Limitations include potential misclassification and unaccounted lifestyle or socioeconomic factors.
Incidence and Survival of Extramammary Paget’s Disease from the Surveillance, Epidemiology, and End Results (SEER) Database
Extramammary Paget’s Disease (EMPD) is a rare intraepithelial neoplasm predominantly affecting the anogenital regions of older, female, and Asian patients. It often progresses insidiously, leading to diagnostic delays spanning years. This study, conducted through a retrospective review of EMPD patients from 22 SEER registries between 2004 and 2020, aimed to analyze contemporary trends in incidence and survival across sexes. The data included various demographics and clinical factors, and age-adjusted incidence rates were calculated over a 20-year period. Survival estimates were assessed using Kaplan-Meier curves, while Cox proportional hazards models were utilized to identify factors associated with all-cause mortality. The study included 3608 patients, with a higher incidence in Asian patients, who had a rate double that of white patients. Notably, the incidence increase was significant only among white patients. Females had a better ten-year survival rate (63.0%) compared to males (53.4%). Multivariable analysis revealed that older age, advanced disease stage, and treatment delays were linked to poorer overall survival, while primary surgical treatment significantly reduced mortality risk compared to no cancer-directed treatment. The study highlights the rising incidence of EMPD and emphasizes the importance of early, complete surgical resection in improving long-term survival outcomes.
Prevalence of extramammary Paget’s disease in urban China: a population-based study
Extramammary Paget’s disease (EMPD) is a rare intraepithelial adenocarcinoma that significantly impacts quality of life due to its chronic and symptomatic nature. A population-based study using data from China’s Urban Employee and Resident Basic Medical Insurance in 2016 aimed to assess EMPD prevalence and its demographic patterns in China, where no national data previously existed. The study identified 84 cases, revealing a crude prevalence of 0.04 per 100,000 population, with regional variations ranging from 0.01 in North/Northeast China to 0.08 in Southwest China. The condition was more common in males (0.05) than females (0.03) and most prevalent among individuals aged 70–79 (0.28). This prevalence is notably lower compared to Western countries, and the Chinese patients were generally younger with a significant male predominance. Further research is needed to explore the underlying mechanisms of EMPD.